Efficient generation and rapid isolation via stoplight recombination of Herpes simplex viruses expressing model antigenic and immunological epitopes

Journal of Virological Methods

Volumn 179, Issue 1, 2012, Pages 116-126

  Sanchez, Rebecca L ^a,b   Ramsay, Alistair J ^a,b   Foster, Timothy P ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b The Louisiana Vaccine Center   (United States)

Author keywords

CD8; Epitopes; Fluorescent; Herpes simplex virus; Ova; Recombination

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; EPITOPE;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL ASSAY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FLUORESCENCE; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; IMMUNOLOGICAL PARAMETERS; MIXED INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE; VIRAL CONTAMINATION; VIRUS CHARACTERIZATION; VIRUS CULTURE; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS PURIFICATION; VIRUS RECOMBINANT; VISUAL DISPLAY UNIT; WESTERN BLOTTING;

ANIMALS; CERCOPITHECUS AETHIOPS; EPITOPES; GENETICS, MICROBIAL; GREEN FLUORESCENT PROTEINS; MOLECULAR BIOLOGY; RECOMBINANT FUSION PROTEINS; RECOMBINATION, GENETIC; SELECTION, GENETIC; SIMPLEXVIRUS; STAINING AND LABELING; VERO CELLS;

HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 84855228423     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.10.009     Document Type: Article

References (56)

1. Barnden M.J., Allison J., Heath W.R., Carbone F.R. Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol. Cell. Biol. 1998, 76:34-40.
2. Bhattacharjee P.S., Neumann D.M., Foster T.P., Clement C., Singh G., Thompson H.W., Kaufman H.E., Hill J.M. Effective treatment of ocular HSK with a human apolipoprotein E mimetic peptide in a mouse eye model. Invest. Ophthalmol. Vis. Sci. 2008, 49:4263-4268.
3. Brandt C.R., Kolb A.W., Shah D.D., Pumfery A.M., Kintner R.L., Jaehnig E., Van Gompel J.J. Multiple determinants contribute to the virulence of HSV ocular and CNS infection and identification of serine 34 of the US1 gene as an ocular disease determinant. Invest. Ophthalmol. Vis. Sci. 2003, 44:2657-2668.
4. Brandt C.R. The role of viral and host genes in corneal infection with herpes simplex virus type 1. Exp. Eye Res. 2005, 80:607-621.
5. Cantin E., Chen J., Willey D.E., Taylor J.L., O'Brien W.J. Persistence of herpes simplex virus DNA in rabbit corneal cells. Invest. Ophthalmol. Vis. Sci. 1992, 33:2470-2475.
6. Carr D.J., Harle P., Gebhardt B.M. The immune response to ocular herpes simplex virus type 1 infection. Exp. Biol. Med. 2001, 226:353-366.
7. David A.T., Baghian A., Foster T.P., Chouljenko V.N., Kousoulas K.G. The herpes simplex virus type 1 (HSV-1) glycoprotein K(gK) is essential for viral corneal spread and neuroinvasiveness. Curr. Eye Res. 2008, 33:455-467.
8. Deshpande S.P., Lee S., Zheng M., Song B., Knipe D., Kapp J.A., Rouse B.T. Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis. J. Virol. 2001, 75:3077-3088.
9. Doymaz M.Z., Foster C.M., Destephano D., Rouse B.T. MHC II-restricted CD4+ cytotoxic T lymphocytes specific for herpes simplex virus-1: implications for the development of herpetic stromal keratitis in mice. Clin. Immunol. Immunopathol. 1991, 61:398-409.
10. Doymaz M.Z., Rouse B.T. Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes. Invest. Ophthalmol. Vis. Sci. 1992, 33:2165-2173.
11. Doymaz M.Z., Rouse B.T. Immunopathology of herpes simplex virus infections. Curr. Top. Microbiol. Immunol. 1992, 179:121-136.
12. Foster T.P., Rybachuk G.V., Kousoulas K.G. Expression of the enhanced green fluorescent protein by herpes simplex virus type 1 (HSV-1) as an in vitro or in vivo marker for virus entry and replication. J. Virol. Methods 1998, 75:151-160.
13. Foster T.P., Kousoulas K.G. Genetic analysis of the role of herpes simplex virus type 1 glycoprotein K in infectious virus production and egress. J. Virol. 1999, 73:8457-8468.
14. Foster T.P., Chouljenko V.N., Kousoulas K.G. Functional characterization of the HveA homolog specified by African green monkey kidney cells with a herpes simplex virus expressing the green fluorescence protein. Virology 1999, 258:365-374.
15. Gangappa S., Deshpande S.P., Rouse B.T. Bystander activation of CD4+ T cells accounts for herpetic ocular lesions. Invest. Ophthalmol. Vis. Sci. 2000, 41:453-459.
16. Ghiasi H., Cai S., Perng G.C., Nesburn A.B., Wechsler S.L. Both CD4+ and CD8+ T cells are involved in protection against HSV-1 induced corneal scarring. Br. J. Ophthalmol. 2000, 84:408-412.
17. Gierasch W.W., Zimmerman D.L., Ward S.L., Vanheyningen T.K., Romine J.D., Leib D.A. Construction and characterization of bacterial artificial chromosomes containing HSV-1 strains 17 and KOS. J. Virol. Methods 2006, 135:197-206.
18. Hendricks R.L., Tao M.S., Glorioso J.C. Alterations in the antigenic structure of two major HSV-1 glycoproteins, gC and gB, influence immune regulation and susceptibility to murine herpes keratitis. J. Immunol. 1989, 142:263-269.
19. Hendricks R.L., Tumpey T.M. Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology. Invest. Ophthalmol. Vis. Sci. 1990, 31:1929-1939.
20. Hendricks R.L. An immunologist's view of herpes simplex keratitis: Thygeson Lecture 1996. Cornea 1997, 16:503-506.
21. Hill J.M., Ball M.J., Neumann D.M., Azcuy A.M., Bhattacharjee P.S., Bouhanik S., Clement C., Lukiw W.J., Foster T.P., Kumar M., Kaufman H.E., Thompson H.W. The high prevalence of herpes simplex virus type 1 DNA in human trigeminal ganglia is not a function of age or gender. J. Virol. 2008, 82:8230-8234.
22. Hogquist K.A., Jameson S.C., Heath W.R., Howard J.L., Bevan M.J., Carbone F.R. T cell receptor antagonist peptides induce positive selection. Cell 1994, 76:17-27.
23. Horsburgh B.C., Hubinette M.M., Tufaro F. Genetic manipulation of herpes simplex virus using bacterial artificial chromosomes. Methods Enzymol. 1999, 306:337-352.
24. Hutchinson L., Johnson D.C. Herpes simplex virus glycoprotein K promotes egress of virus particles. J. Virol. 1995, 69:5401-5413.
25. Jayachandra S., Baghian A., Kousoulas K.G. Herpes simplex virus type 1 glycoprotein K is not essential for infectious virus production in actively replicating cells but is required for efficient envelopment and translocation of infectious virions from the cytoplasm to the extracellular space. J. Virol. 1997, 71:5012-5024.
26. Jugovic P., Hill A.M., Tomazin R., Ploegh H., Johnson D.C. Inhibition of major histocompatibility complex class I antigen presentation in pig and primate cells by herpes simplex virus type 1 and 2 ICP47. J. Virol. 1998, 72:5076-5084.
27. Karttunen J., Sanderson S., Shastri N. Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:6020-6024.
28. Kaye S., Choudhary A. Herpes simplex keratitis. Prog. Retin. Eye Res. 2006, 25:355-380.
29. Klupp B.G., Baumeister J., Dietz P., Granzow H., Mettenleiter T.C. Pseudorabies virus glycoprotein gK is a virion structural component involved in virus release but is not required for entry. J. Virol. 1998, 72:1949-1958.
30. Lepisto A.J., Frank G.M., Xu M., Stuart P.M., Hendricks R.L. CD8 T cells mediate transient herpes stromal keratitis in CD4-deficient mice. Invest. Ophthalmol. Vis. Sci. 2006, 47:3400-3409.
31. Liesegang T.J. Herpes simplex virus epidemiology and ocular importance. Cornea 2001, 20:1-13.
32. Maggs D.J., Chang E., Nasisse M.P., Mitchell W.J. Persistence of herpes simplex virus type 1 DNA in chronic conjunctival and eyelid lesions of mice. J. Virol. 1998, 72:9166-9172.
33. Melancon J.M., Luna R.E., Foster T.P., Kousoulas K.G. Herpes simplex virus type 1 gK is required for gB-mediated virus-induced cell fusion, while neither gB and gK nor gB and UL20p function redundantly in virion de-envelopment. J. Virol. 2005, 79:299-313.
34. Metcalf J.F., Kaufman H.E. Herpetic stromal keratitis-evidence for cell-mediated immunopathogenesis. Am. J. Ophthalmol. 1976, 82:827-834.
35. Metcalf J.F., Hamilton D.S., Reichert R.W. Herpetic keratitis in athymic (nude) mice. Infect. Immun. 1979, 26:1164-1171.
36. Metcalf J.F., Michaelis B.A. Herpetic keratitis in inbred mice. Invest. Ophthalmol. Vis. Sci. 1984, 25:1222-1225.
37. Mo C., Suen J., Sommer M., Arvin A. Characterization of Varicella-Zoster virus glycoprotein K (open reading frame 5) and its role in virus growth. J. Virol. 1999, 73:4197-4207.
38. Mocarski E.S. Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system. Cell. Microbiol. 2004, 6:707-717.
39. Neumann J., Eis-Hubinger A.M., Koch N. Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion. J. Immunol. 2003, 171:3075-3083.
40. Newell C.K., Martin S., Sendele D., Mercadal C.M., Rouse B.T. Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology. J. Virol. 1989, 63:769-775.
41. Newell C.K., Sendele D., Rouse B.T. Effects of CD4+ and CD8+ T-lymphocyte depletion on the induction and expression of herpes simplex stromal keratitis. Reg. Immunol. 1989, 2:366-369.
42. Niemialtowski M.G., Godfrey V.L., Rouse B.T. Quantitative studies on CD4+ and CD8+ cytotoxic T lymphocyte responses against herpes simplex virus type 1 in normal and beta 2-m deficient mice. Immunobiology 1994, 190:183-194.
43. Osorio Y., Cai S., Hofman F.M., Brown D.J., Ghiasi H. Involvement of CD8+ T-cells in exacerbation of corneal scarring in mice. Curr. Eye Res. 2004, 29:145-151.
44. Pepose J.S., Leib D.A., Stuart P.M., Easty D.L. Herpes simplex virus disease. Anterior segment of the eye. Ocular Infection and Immunity 1996, 905-929. Mosby, St. Louis, MO. J.S. Pepose, G.N. Holland, K.R. Wilhelmus (Eds.).
45. Pinto A.K., Hill A.B. Viral interference with antigen presentation to CD8+ T cells: lessons from cytomegalovirus. Viral Immunol. 2005, 18:434-444.
46. Russell R.G., Nasisse M.P., Larsen H.S., Rouse B.T. Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis. Invest. Ophthalmol. Vis. Sci. 1984, 25:938-944.
47. Shastri N., Gonzalez F. Endogenous generation and presentation of the ovalbumin peptide/Kb complex to T cells. J. Immunol. 1993, 150:2724-2736.
48. Smith T.J., Morrison L.A., Leib D.A. Pathogenesis of herpes simplex virus type 2 virion host shutoff (vhs) mutants. J. Virol. 2002, 76:2054-2061.
49. Streilein J.W., Dana M.R., Ksander B.R. Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol. Today 1997, 18:443-449.
50. Stuart P.M., Summers B., Morris J.E., Morrison L.A., Leib D.A. CD8(+) T cells control corneal disease following ocular infection with herpes simplex virus type 1. J. Gen. Virol. 2004, 85:2055-2063.
51. Thomas P.G., Brown S.A., Morris M.Y., Yue W., So J., Reynolds C., Webby R.J., Doherty P.C. Physiological numbers of CD4+ T cells generate weak recall responses following influenza virus challenge. J. Immunol. 2010, 184:1721-1727.
52. Toma H.S., Murina A.T., Areaux R.G., Neumann D.M., Bhattacharjee P.S., Foster T.P., Kaufman H.E., Hill J.M. Ocular HSV-1 latency, reactivation and recurrent disease. Semin. Ophthalmol. 2008, 23:249-273.
53. Tomazin R., Hill A.B., Jugovic P., York I., van Endert P., Ploegh H.L., Andrews D.W., Johnson D.C. Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J. 1996, 15:3256-3266.
54. Whitley R.J. Herpes simplex viruses. Fields Virology 1996, 2297-2342. Lippincott/Raven, Philadelphia, PA. B.N. Fields, D.M. Knipe, P.M. Howley (Eds.).
55. Williams L.E., Nesburn A.B., Kaufman H.E. Experimental induction of disciform keratitis. Arch. Ophthalmol. 1965, 73:112-114.
56. Yewdell J.W., Hill A.B. Viral interference with antigen presentation. Nat. Immunol. 2002, 3:1019-1025.